The Sage Group

Volume II Peripheral Arterial Disease A Significant Opportunity for Interventional Therapies

Underestimated, Underdiagnosed and Undertreated A Significant Opportunity for Interventional Therapies

Analyzes the peripheral interventional market in the aortoiliac, femoropopliteal and tibial vessels. Provides in-depth discussion of surgical bypass and grafts, angioplasty, stents, stent-grafts and other FDA-approved endovascular therapies. These include atherectomy, PolarCath cryoplasty, the CLiRpath excimer laser, the SilverHawk System, the cutting balloon and new devices to cross total occlusions.

Estimates current market potential for bypass surgery and endovascular therapies by disease severity and projects growth through 2020. Provides information and financial data for over 30 company participants.

Price: $4,250

To purchase call us at 404 520-6652 or contact